|
Case number
|
EHPM site
|
EHPM groupa
|
pTNM stage†
|
Follow up or survival duration (months)
|
Cause of deathb
|
|---|
|
T
|
N
|
M
|
Stage
|
|---|
|
1
|
Rectum
|
S
|
3
|
0
|
0
|
IIA
|
118
| |
|
2*
|
Breast
|
S
|
1
|
0
|
0
|
IA
|
4
|
H
|
|
3*
|
Stomach
|
S
|
3
|
3
|
1
|
IV
|
10
|
E
|
|
4*
|
Stomach
|
S
|
1
|
0
|
0
|
IA
|
21
|
E and O
|
|
5
|
Breast
|
S
|
1
|
0
|
0
|
IA
|
53
| |
|
6*
|
Kidney
|
S
|
1
|
0
|
0
|
I
|
0
|
H
|
|
7*
|
Rectum
|
S
|
3
|
2
|
0
|
IIIB
|
12
|
H
|
|
8
|
Esophagus
|
S
|
1
|
0
|
0
|
IA
|
52
| |
|
9
|
Kidney
|
S
|
1
|
0
|
0
|
I
|
51
| |
|
10
|
Colon
|
S
|
3
|
0
|
0
|
IIA
|
48
| |
|
11
|
Stomach (MALToma)
|
S
| | | |
IEA(Ann Arbor)
|
47
| |
|
12
|
Colon
|
S
|
3
|
0
|
0
|
IIA
|
32
| |
|
13
|
Colon
|
S
|
3
|
0
|
0
|
IIA
|
28
| |
|
14
|
Retroperitoneum
|
S
|
2b
|
0
|
0
|
Ib
|
35
| |
|
15*
|
Multiple myeloma
|
S
| | | |
III(ISS)
|
23
|
E
|
|
16
|
Stomach
|
S
|
is
|
0
|
0
|
0
|
17
| |
|
17*
|
Rectum
|
S
|
3
|
1
|
0
|
IIIB
|
4
|
O
|
|
18*
|
Rectum
|
S
|
4b
|
2b
|
0
|
IIIC
|
3
|
H and E
|
|
19*
|
Stomach
|
M
|
3
|
0
|
0
|
IIA
|
16
|
H
|
|
20*
|
Kidney
|
P
|
NA
| | | |
18
|
H
|
|
21
|
Pancreas
|
M
|
3
|
1
|
0
|
IIIB
|
55
| |
|
22
|
Prostate
|
M
|
3
|
0
|
0
|
III
|
74
| |
|
23
|
Breast
|
P
|
2
|
0
|
0
|
IIA
|
46
| |
|
24
|
Colon
|
P
|
2
|
0
|
0
|
I
|
27
| |
|
Stomach
|
P
|
1b
|
0
|
0
|
IA
|
|
25
|
Colon
|
M
|
3
|
0
|
1
|
IVA
|
38
| |
|
26
|
Colon
|
M
|
NA
| | | |
24
| |
|
27
|
Thyroid
|
M
|
3
|
1a
|
0
|
III
|
29
| |
|
28
|
CBD
|
M
|
4
|
1
|
0
|
III
|
109
| |
|
29
|
Stomach
|
P
|
1
|
0
|
0
|
IA
|
17
| |
|
30
|
Stomach
|
P
|
NA
| | | |
0
| |
|
31*
|
Breast
|
P
|
1
|
0
|
0
|
IA
|
1
|
O
|
|
32
|
Stomach
|
P
|
1
|
0
|
0
|
IA
|
20
| |
|
33
|
Bladder
|
M.
|
1
|
0
|
0
|
I
|
100
| |
- CBD, common bile duct; EHPM, extrahepatic primary malignant neoplasm; HCC, hepatocellular carcinoma; is, in situ; NA, not applicable; pTNM stage, pathologic TNM stage.
- aM, metachronous group; P, prior group; S, synchronous group.
- bH, HCC related; E, EHPM related; O, Others.
- †Based on AJCC 7th edition, except Ann Arbor Staging for gastric lymphoma (MALToma) and ISS (International Staging System) for multiple myeloma.
- *Patient who expired.
